A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea
Clinical trial NCT06698887 · RECRUITING
Trial details
- NCT number
- NCT06698887
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-11
- Primary completion
- 2031-03-27
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.